Vimliv is a comprehensive hepatoprotective formulation for the management of liver diseases.
Benefits:
 |
Accelerates biochemical recovery
|
| |
|
|
| |
|
Improves
hepatic antioxidant status
|
|
|
Improves appetite and digestion |
Composition:
| Each coated tablet contains
ext. of:
|
 |
| Tamalaki [Bhumyamalaki] (Phyllanthus niruri) |
200 mg
|
|
| Bhrungaraja (Eclipta alba)
|
200 mg
|
| |
| Kasni (Cichorium intybus) |
150 mg
|
|
| Punarnava (Boerhaavia diffusa)
|
100 mg
|
|
| Vidanga (Embelia ribes)
|
50 mg
|
|
| Daruharidra (Berberis aristata)
|
50 mg
|
|
| Katuki (Picrorrhiza kurroa) |
10 mg |
Clinical trial of Tab. Vimliv conducted in Gastroenterology Dept. of B.Y.L Nair Hospital & TN Medical College, Mumbai indicates that Tab. Vimliv is safe and effective in decreasing symptoms and improving liver biochemistry in patients with Alcoholic Hepatitis.
Indications: In liver disorders such as Fatty liver,
Alcoholic Hepatitis, Drug induced Hepatitis and Viral hepatitis.
Dosage: Children: One tablet thrice daily.
Adults: Two tablets thrice daily or as directed by the physician.
Presentation: 750 Tablets
|
